Skip to main content
. Author manuscript; available in PMC: 2019 Jul 25.
Published in final edited form as: Liver Transpl. 2015 Jun;21(6):823–830. doi: 10.1002/lt.24126

TABLE 5.

Baseline Immunosuppression and Changes While on Therapy

METAVIR METAVIR
F0-F2 (n 5 38) F3-F4 (n 5 23) P Value
Tacrolimus monotherapy 23 (60.5) 14 (60.9)
Tacrolimus/MMF 9 (23.7) 5 (21.7)
Tacrolimus dose reduction 11 (28.9) 1 (4.3) 0.007
Tacrolimus dose increased 0 3 (13)
Cyclosporine/MMF 2 (5.3) 1 (4.3)
mTOR monotherapy 2 (5.3) 1 (4.3)
mTOR/MMF 2 (5.3) 2 (8.7)
mTOR dose reduction 1 (2.6) 0

NOTE: Data are given as n (%).